BIOREM Inc.
BRM.V
TSX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -25.14% | 27.76% | -24.91% | -25.83% | 165.70% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -25.14% | 27.76% | -24.91% | -25.83% | 165.70% |
| Cost of Revenue | -18.81% | 20.59% | -17.81% | -3.83% | 144.65% |
| Gross Profit | -37.57% | 52.18% | -41.42% | -64.77% | 219.78% |
| SG&A Expenses | -24.22% | 29.14% | -20.17% | -7.31% | 147.62% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -100.00% | -- | -- | -- | -- |
| Total Operating Expenses | -19.41% | 22.00% | -18.33% | -4.93% | 145.20% |
| Operating Income | -47.65% | 103.87% | -87.76% | -89.20% | 295.81% |
| Income Before Tax | -47.71% | 116.75% | -89.79% | -92.21% | 328.51% |
| Income Tax Expenses | -47.71% | 116.87% | -89.63% | -89.90% | 328.62% |
| Earnings from Continuing Operations | -47.71% | 116.79% | -89.85% | -92.87% | 328.47% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -47.71% | 116.79% | -89.85% | -92.87% | 328.47% |
| EBIT | -47.65% | 103.87% | -87.76% | -89.20% | 295.81% |
| EBITDA | -46.58% | 96.35% | -69.28% | -86.98% | 294.36% |
| EPS Basic | -48.38% | 112.66% | -91.41% | -92.81% | 325.52% |
| Normalized Basic EPS | -48.44% | 111.85% | -91.30% | -92.19% | 326.11% |
| EPS Diluted | -47.98% | 118.94% | -90.07% | -117.34% | 286.16% |
| Normalized Diluted EPS | -47.61% | 115.79% | -89.92% | -91.64% | 302.75% |
| Average Basic Shares Outstanding | 1.31% | 2.12% | 18.80% | -0.64% | 0.65% |
| Average Diluted Shares Outstanding | -0.06% | 0.44% | 2.60% | -7.26% | 6.52% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |